Eli Lilly's diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall Street had expected.
, and doctors have already been prescribing it off-label for that.
If approved, Lilly’s drug would compete with Novo Nordisk’s popular weight loss drug Wegovy — also sold to manage diabetes under the brand Ozempic — in a wave of new options that is changing the treatment of obesity. The Danish drugmaker said weekly injections of the highest dose of the medication known generically as semaglutide slashed the risk of heart attack, stroke and heart disease-related deaths in people who were overweight or obese and had known cardiovascular disease, but not type 2 diabetes.
In the recently completed second quarter, Mounjaro sales helped lift Indianapolis-based Eli Lilly and Co. to a better-than-expected performance.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Eli Lilly Raises Forecasts with Diabetes Drug Mounjaro's Strong PerformancePharmaceutical company Eli Lilly has increased its forecasts after its diabetes drug Mounjaro delivers positive results, boosting the company's outlook.
Weiterlesen »
Morgan Stanley predicts Eli Lilly shares to rally on Novo's obesity drug dataMorgan Stanley believes that the positive data on Novo Nordisk's obesity drug Wegovy will also benefit Eli Lilly, leading to a potential increase in its stock value. Novo Nordisk's shares surged by 15% following the release of late-stage trial data, which demonstrated that Wegovy reduced the risk of major cardiovascular events by 20% compared to a placebo.
Weiterlesen »
Ozempic and Mounjaro makers sued by patient alleging ‘severe gastrointestinal issues'The medications are used to treat Type 2 diabetes and have become popular weight-loss drugs.
Weiterlesen »
Patient Sues Ozempic and Mounjaro Makers Over Severe Gastrointestinal IssuesA patient from Louisiana has filed a lawsuit against Novo Nordisk, the maker of Ozempic, and Eli Lilly, the maker of Mounjaro, alleging that they failed to adequately warn about the potential adverse side effects of the medications, including the risk of gastroparesis.
Weiterlesen »
Eli McCann: Welcome to a Big Fat Mormon Wedding — where cousins arrive by the dozensSalt Lake Tribune guest columnist Eli McCann talks about large Latter-day Saint families and their big, yet not-so-big, weddings.
Weiterlesen »
Dolphins’ Tyreek Hill excited to ‘embarrass’ Eli Apple at practice as they squash beefApparently, when it comes to the perceived beef between Tyreek Hill and Eli Apple, the former thinks people read too much into their social media interactions.
Weiterlesen »